Dropped head syndrome: report of three cases during treatment with a MEK inhibitor

Neurology. 2012 Oct 30;79(18):1929-31. doi: 10.1212/WNL.0b013e318271f87e. Epub 2012 Oct 17.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Benzimidazoles / administration & dosage
  • Benzimidazoles / adverse effects*
  • Female
  • Humans
  • MAP Kinase Kinase 1 / antagonists & inhibitors*
  • MAP Kinase Kinase 2 / antagonists & inhibitors*
  • Male
  • Melanoma / drug therapy
  • Melanoma / enzymology
  • Neuromuscular Diseases / chemically induced*
  • Neuromuscular Diseases / enzymology
  • Protein Kinase Inhibitors / therapeutic use*
  • Syndrome
  • Uveal Neoplasms / drug therapy
  • Uveal Neoplasms / enzymology

Substances

  • AZD 6244
  • Benzimidazoles
  • Protein Kinase Inhibitors
  • MAP2K2 protein, human
  • MAP Kinase Kinase 1
  • MAP Kinase Kinase 2
  • MAP2K1 protein, human

Supplementary concepts

  • Uveal melanoma

Associated data

  • ClinicalTrials.gov/NCT01143402